Phase 1/2 study of the selective TRK inhibitor larotrectinib, in pediatric patients with cancer Meeting Abstract
| Authors: | Gallego Mélcon, S.; Casanova, M.; Bielack, S.; Chisholm, J.; van Tilburg, C. S.; Federman, N.; Albert, C. M.; Mascarenhas, L.; Turpin, B.; Nagasubramanian, R.; Shukla, N.; Spunt, S.; Cox, M. C.; Hawkins, D. S.; Pappo, A. S.; Doz, F.; Bisogno, G.; Dubois, S. G.; Laetsch, T. W.; Geoerger, B. |
| Abstract Title: | Phase 1/2 study of the selective TRK inhibitor larotrectinib, in pediatric patients with cancer |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx367.051 |
| Language: | English |
| ACCESSION: | WOS:000411324001076 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx367.051 |
| Notes: | Meeting Abstract: 418TiP -- Appears on page 139 of the abstract book -- Source: Wos |
